" /> " />

Merck Earnings Estimate

MRK Stock  USD 130.99  0.20  0.15%   
The next projected EPS of Merck is estimated to be 2.14 with future projections ranging from a low of 2.0 to a high of 2.25. Merck's most recent 12-month trailing earnings per share (EPS TTM) is at 0.91. Please be aware that the consensus of earnings estimates for Merck Company is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Merck is projected to generate 2.14 in earnings per share on the 30th of June 2024. Merck earnings estimates module stress-tests analyst consensus about projected Merck Company EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Merck, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Merck Revenue Breakdown by Earning Segment

By analyzing Merck's earnings estimates, investors can diagnose different trends across Merck's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Merck's Gross Profit is quite stable compared to the past year. Gross Profit Margin is expected to rise to 0.74 this year, although the value of Pretax Profit Margin will most likely fall to 0.03.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Merck Earnings Estimation Breakdown

The calculation of Merck's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Merck is estimated to be 2.14 with the future projection ranging from a low of 2.0 to a high of 2.25. Please be aware that this consensus of annual earnings estimates for Merck Company is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
2.07
2.00
Lowest
Expected EPS
2.14
2.25
Highest

Merck Earnings Projection Consensus

Suppose the current estimates of Merck's value are higher than the current market price of the Merck stock. In this case, investors may conclude that Merck is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Merck's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2024Current EPS (TTM)
2187.34%
2.07
2.14
0.91

Merck Earnings History

Earnings estimate consensus by Merck Company analysts from Wall Street is used by the market to judge Merck's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Merck's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Merck Quarterly Gross Profit

11.29 Billion

Price Earnings Ratio is expected to rise to 795.65 this year, although the value of Retained Earnings will most likely fall to about 32.6 B. Common Stock Shares Outstanding is expected to rise to about 2.7 B this year. Net Income Applicable To Common Shares is expected to rise to about 17.5 B this year.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merck's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
129.94130.99132.04
Details
Intrinsic
Valuation
LowRealHigh
103.74104.79144.09
Details
Naive
Forecast
LowNextHigh
129.62130.67131.72
Details
28 Analysts
Consensus
LowTargetHigh
106.65117.20130.09
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Merck. Your research has to be compared to or analyzed against Merck's peers to derive any actionable benefits. When done correctly, Merck's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Merck Company. Note that many institutional investors and large investment bankers can move markets due to the volume of Merck assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Merck. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Merck's stock price in the short term.

Merck Earnings per Share Projection vs Actual

Actual Earning per Share of Merck refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Merck Company predict the company's earnings will be in the future. The higher the earnings per share of Merck, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Merck Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Merck, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Merck should always be considered in relation to other companies to make a more educated investment decision.

Merck Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-28
2024-03-311.872.070.210 
2024-02-01
2023-12-31-0.110.030.14127 
2023-10-26
2023-09-301.952.130.18
2023-08-01
2023-06-30-2.18-2.060.12
2023-04-27
2023-03-311.321.40.08
2023-02-02
2022-12-311.541.620.08
2022-10-27
2022-09-301.711.850.14
2022-07-28
2022-06-301.71.870.1710 
2022-04-28
2022-03-311.832.140.3116 
2022-02-03
2021-12-311.531.80.2717 
2021-10-28
2021-09-301.551.750.212 
2021-07-29
2021-06-301.311.310.0
2021-04-29
2021-03-311.631.4-0.2314 
2021-02-04
2020-12-311.381.32-0.06
2020-10-27
2020-09-301.441.740.320 
2020-07-31
2020-06-301.041.370.3331 
2020-04-28
2020-03-311.341.50.1611 
2020-02-05
2019-12-311.151.160.01
2019-10-29
2019-09-301.241.510.2721 
2019-07-30
2019-06-301.161.30.1412 
2019-04-30
2019-03-311.061.220.1615 
2019-02-01
2018-12-311.031.040.01
2018-10-25
2018-09-301.141.190.05
2018-07-27
2018-06-301.031.060.03
2018-05-01
2018-03-3111.050.05
2018-02-02
2017-12-310.940.980.04
2017-10-27
2017-09-301.031.110.08
2017-07-28
2017-06-300.871.010.1416 
2017-05-02
2017-03-310.830.880.05
2017-02-02
2016-12-310.890.890.0
2016-10-25
2016-09-300.991.070.08
2016-07-29
2016-06-300.910.930.02
2016-05-05
2016-03-310.850.890.04
2016-02-03
2015-12-310.910.930.02
2015-10-27
2015-09-300.910.960.05
2015-07-28
2015-06-300.810.860.05
2015-04-28
2015-03-310.750.850.113 
2015-02-04
2014-12-310.850.870.02
2014-10-27
2014-09-300.880.90.02
2014-07-29
2014-06-300.810.850.04
2014-04-29
2014-03-310.790.880.0911 
2014-02-05
2013-12-310.890.88-0.01
2013-10-28
2013-09-300.880.920.04
2013-07-30
2013-06-300.830.840.01
2013-05-01
2013-03-310.790.850.06
2013-02-01
2012-12-310.810.830.02
2012-10-26
2012-09-300.920.950.03
2012-07-27
2012-06-301.011.050.04
2012-02-02
2011-12-310.950.970.02
2011-10-28
2011-09-300.910.940.03
2011-07-29
2011-06-300.950.950.0
2011-04-29
2011-03-310.840.920.08
2011-02-03
2010-12-310.830.880.05
2010-10-29
2010-09-300.820.850.03
2010-07-30
2010-06-300.830.860.03
2010-05-04
2010-03-310.750.830.0810 
2010-02-16
2009-12-310.790.790.0
2009-10-22
2009-09-300.820.90.08
2009-07-21
2009-06-300.770.830.06
2009-04-21
2009-03-310.770.74-0.03
2009-02-03
2008-12-310.740.870.1317 
2008-10-22
2008-09-300.790.80.01
2008-07-21
2008-06-300.830.860.03
2008-04-21
2008-03-310.860.890.03
2008-01-30
2007-12-310.740.80.06
2007-10-22
2007-09-300.690.750.06
2007-07-23
2007-06-300.720.820.113 
2007-04-19
2007-03-310.840.840.0
2007-01-30
2006-12-310.50.50.0
2006-10-20
2006-09-300.50.510.01
2006-07-24
2006-06-300.650.730.0812 
2006-04-20
2006-03-310.720.780.06
2006-01-31
2005-12-310.620.640.02
2005-10-24
2005-09-300.620.650.03
2005-07-21
2005-06-300.620.620.0
2005-04-21
2005-03-310.590.620.03
2005-01-25
2004-12-310.50.50.0
2004-10-21
2004-09-300.710.6-0.1115 
2004-07-21
2004-06-300.790.790.0
2004-04-22
2004-03-310.720.730.01
2004-01-27
2003-12-310.620.620.0
2003-10-22
2003-09-300.850.83-0.02
2003-07-21
2003-06-300.840.83-0.01
2003-04-21
2003-03-310.760.760.0
2003-01-28
2002-12-310.830.830.0
2002-10-18
2002-09-300.830.830.0
2002-07-19
2002-06-300.770.770.0
2002-04-18
2002-03-310.710.710.0
2002-01-22
2001-12-310.80.810.01
2001-10-18
2001-09-300.830.840.01
2001-07-20
2001-06-300.780.780.0
2001-04-20
2001-03-310.710.710.0
2001-01-23
2000-12-310.750.750.0
2000-10-20
2000-09-300.730.780.05
2000-07-24
2000-06-300.690.730.04
2000-04-24
2000-03-310.620.630.01
2000-01-26
1999-12-310.660.660.0
1999-10-21
1999-09-300.640.640.0
1999-07-23
1999-06-300.610.610.0
1999-04-23
1999-03-310.540.550.01
1999-01-26
1998-12-310.580.580.0
1998-10-16
1998-09-300.560.560.0
1998-07-21
1998-06-300.540.560.02
1998-04-16
1998-03-310.480.480.0
1998-01-27
1997-12-310.510.520.01
1997-10-16
1997-09-300.50.50.0
1997-07-17
1997-06-300.480.480.0
1997-04-16
1997-03-310.420.420.0
1997-01-28
1996-12-310.430.440.01
1996-10-16
1996-09-300.410.420.01
1996-07-18
1996-06-300.40.40.0
1996-04-17
1996-03-310.350.350.0
1996-01-23
1995-12-310.350.350.0

About Merck Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Merck earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Merck estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Merck fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings53.9 B32.6 B
Retained Earnings Total Equity70.2 B46 B
Earnings Yield 0  0 
Price Earnings Ratio 757.76  795.65 
Price Earnings To Growth Ratio(7.77)(7.38)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Merck Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.685
Dividend Share
2.96
Earnings Share
0.91
Revenue Per Share
24.215
Quarterly Revenue Growth
0.089
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.